- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04105647
Lifestyle Modification Program for Lung Cancer Patients - A Pilot Study
A Brief Messaging Lifestyle Modification Program for Patients With Non-small Cell Lung Cancer - A Pilot Study
Lung cancer is one of the most common cancer diseases, globally and locally. Several health benefits of increased physical activity (PA) have been reported for people with cancer. PA plays a critical role across the cancer trajectory, from prevention through to post-diagnosis and has been proposed as an alternative for improving physical and psychosocial health outcomes, reducing cancer recurrence, and cancer-specific and all-cause mortality.
Although there are a variety of exercise intervention programs for cancer patients, those programs were quite intensive, requiring individuals to commit extra time and effort. Feeling of overwhelmed appointments, lack of time, other barriers, including high cost and limited access to facilities are the most frequently reported barriers that prevent people from starting and maintaining exercise. Hence, the investigators propose to use a brief messaging lifestyle modification intervention program to incorporating simple and easy-to-do patient-centred home-based lifestyle-integrated exercise into daily activities of patients with lung cancer. The aims are to increase patients' physical activity and improve their fatigue, emotion and quality of life, compared to the control group.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Lung cancer is one of the most common cancer, globally and locally. Patients with lung cancer are in a uniquely challenging situation in their disease, comorbidities, and treatment that may lead to worsened symptoms and many negative health consequences, including fatigue, irritability, and impaired daytime functioning.
Physical activity (PA) is defined as 'any bodily movement produced by skeletal muscle that results in energy expenditure'. Several health benefits of increased PA have been reported for people with cancer. PA plays a critical role across the cancer trajectory, from prevention through to post-diagnosis and has been proposed as an alternative for improving physical and psychosocial health outcomes, reducing cancer recurrence, and cancer-specific and all-cause mortality. Although there are a variety of exercise intervention programs for cancer patients, those programs were quite intensive, requiring individuals to commit extra time and effort. Most clinicians underutilise exercise therapy, regardless of its low-cost way to improve symptoms and potential health outcomes. Feeling of overwhelmed appointments, lack of time, other barriers, including high cost and limited access to facilities are the most frequently reported barriers that prevent people from starting and maintaining exercise. Low motivation, fear to exercise, lack of knowledge about benefits are the most common barriers of engaging in physical activity for cancer patients.
Hence, the current proposal is to use a brief messaging lifestyle modification intervention program to incorporating simple and easy-to-do patient-centred home-based lifestyle-integrated exercise (light to moderate physical activity) into daily activities of patients with lung cancer.
The investigators hypothesised that patients in the experimental group would display significantly higher increases in physical activity and improvements in fatigue, emotion and quality of life, compared to the control group.
The objectives are to examine the short-term clinical effects on impacts on fatigue, emotion and quality of life in patients with lung cancer, and to evaluate the feasibility of a brief lifestyle-integrated exercise program to increase physical activity by a pilot study with objective fitness and subjective questionnaire assessment, and focus group interviews.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hong Kong, Hong Kong
- Recruiting
- Queen Mary Hospital
-
Principal Investigator:
- Agnes YK Lai, PhD
-
Contact:
- Agnes YK Lai, PhD
- Phone Number: 852-3917-6328
- Email: agneslai@hku.hk
-
Contact:
- Mary MS Ip, MD
- Phone Number: 852-2255-4455
- Email: msmip@hku.hk
-
Hong Kong, Hong Kong, 852
- Recruiting
- Agnes
-
Principal Investigator:
- Agnes YK Lai, PhD
-
Contact:
- Agnes YK Lai
- Email: agneslai@hku.hk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Aged 18 years and above;
- Diagnosis with non-small cell lung cancer
- General condition stable, either is undergoing or finished treatment
- Able to speak and read Chinese
- Able to complete the self-administered questionnaire
- Able to use instant messages such as WhatsApp or WeChat
- Mental, cognitive and physically fit determined by the clinicians/investigators
- Signed informed consent
Exclusion Criteria:
- Pre-operative lung cancer
- Skeletal fragility
- Serious active infection
- Inability to walk
- Previously untreated symptomatic brain metastases
- Severe respiratory insufficiency
- Uncontrolled pain
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental group
Patients in the experimental group will receive a face-to-face group session and a package of healthy lifestyle instant messages, including lifestyle-integrated exercise and physical activity.
|
The experimental group will receive a face-to-face group session and a package of instant messages related to lifestyle-integrated exercise and physical activity.
The lifestyle-integrated exercise is modified from Zero-time exercise.
It focuses on four exercise domains that patients with lung cancer could be done at home, including breathing, balance, aerobic, strength, stretching exercises
Other Names:
|
|
Placebo Comparator: Control group
The control group will receive a face-to-face group session and a package of healthy lifestyle instant messages, but not related to lifestyle-integrated exercise and physical activity.
|
The control group will receive a face-to-face group session and a package healthy living instant messages, but not related to lifestyle-integrated exercise and physical activity.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in fatigue level at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by Brief Fatigue Inventory
|
Baseline and 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in physical activity at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by International Physical Assessment Questionnaire - Short version
|
Baseline and 6 weeks
|
|
Change in health-related quality of life at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by European Organisation for Research and Treatment of Cancer and lung module questionnaire
|
Baseline and 6 weeks
|
|
Change in functional level at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by Functional Assessment Cancer Therapy - Lung (FACT-L) questionnaire
|
Baseline and 6 weeks
|
|
Change in anxiety and depression symptoms at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by Hospital Anxiety and Depression Scale.
Each item is answered on a 4-point scale (0-3).
The scores for the seven questions on depression are added together to obtain a score ranged from 0 to 21.
The higher score the more depressed.
The scores for the seven questions on anxiety are added together to obtain a score ranged from 0 to 21.
The higher score the more anxiety.
|
Baseline and 6 weeks
|
|
Change in insomnia level at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by Insomnia Severity Index
|
Baseline and 6 weeks
|
|
Change in sleep quality at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by Pittsburgh Sleep Quality Index
|
Baseline and 6 weeks
|
|
Change in excessive daytime sleepiness at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by Epworth Sleepiness Scale.
It is a scale of increasing probability from 0 to 3 for eight different situations that most people engage in during their daily lives, though not necessarily every day.
The scores for the eight questions are added together to obtain a score ranged from 0 to 24.
The higher score the more sleepiness.
|
Baseline and 6 weeks
|
|
Change in activity level at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by fitbits
|
Baseline and 6 weeks
|
|
Change in hand grips strength at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by a dynamometer
|
Baseline and 6 weeks
|
|
Change in lower limb strength at 6 weeks
Time Frame: Baseline and 6 weeks
|
assessed by using a 30-second chair stand test to record the number of stands from chair in 30 seconds
|
Baseline and 6 weeks
|
|
Change in balance at 6 weeks
Time Frame: Baseline and 6 weeks
|
assessed by a single-leg-stance test by recording the time within which the individual could effectively achieve balance on one leg
|
Baseline and 6 weeks
|
|
Change in flexibility at 6 weeks
Time Frame: Baseline and 6 weeks
|
assessed by chair sit and reach test
|
Baseline and 6 weeks
|
|
Change in endurance at 6 weeks
Time Frame: Baseline and 6 weeks
|
assessed by 6-minute walk
|
Baseline and 6 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Agnes Lai, The University of Hong Kong
Publications and helpful links
General Publications
- Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep. 1985 Mar-Apr;100(2):126-31.
- Peddle-McIntyre CJ, Singh F, Thomas R, Newton RU, Galvao DA, Cavalheri V. Exercise training for advanced lung cancer. Cochrane Database Syst Rev. 2019 Feb 11;2(2):CD012685. doi: 10.1002/14651858.CD012685.pub2.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UW19-597-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.